ERO1L Antibody [DyLight 594]
Novus Biologicals, part of Bio-Techne | Catalog # NB100-2525DL594
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human, Mouse, Rat
Applications
Immunocytochemistry/ Immunofluorescence, Western Blot
Label
DyLight 594 (Excitation = 593 nm, Emission = 618 nm)
Antibody Source
Polyclonal Rabbit IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
A synthetic peptide made to the N-terminal region of human ERO1L [UniProt Q96HE7]
Reactivity Notes
Use in Rat reported in scientific literature (PMID:34512174).
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Applications for ERO1L Antibody [DyLight 594]
Application
Recommended Usage
Immunocytochemistry/ Immunofluorescence
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: ERO1L alpha
Long Name
Endoplasmic Reticulum Oxidoreductin 1 alpha
Alternate Names
ERO1-alpha, ERO1-L, ERO1-l alpha, ERO1-like, ERO1-like alpha, ERO1A, ERO1L
Gene Symbol
ERO1A
Additional ERO1L alpha Products
Product Documents for ERO1L Antibody [DyLight 594]
Product Specific Notices for ERO1L Antibody [DyLight 594]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...